NCT05092763 Prehabilitation During the Neoadjuvant Window of Opportunity in Older Women With Ovarian Cancer Status COMPLETED Phase NA
NCT05082025 Phase 2 Study of PI3K Inhibitor Copanlisib in Combination With Fulvestrant in Selected ER+ and/or PR+ Cancers With PI3K (PIK3CA, PIK3R1) and/or PTEN Alterations Status TERMINATED Phase PHASE2
NCT05080946 Using Aspirin to Improve Immunological Features of Ovarian Tumors Status RECRUITING Phase EARLY_PHASE1
NCT05080556 Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer Status RECRUITING Phase PHASE2
NCT05071937 ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer Status RECRUITING Phase PHASE2
NCT05065021 Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor Status RECRUITING Phase PHASE2
NCT05061537 Study of PF-07263689 in Participants With Selected Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT05059782 Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer Status UNKNOWN Phase NA
NCT05059522 Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05057013 A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05056077 Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit) Status ACTIVE_NOT_RECRUITING Phase NA
NCT05053230 A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer Status RECRUITING Phase NA
NCT05051722 Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer Status RECRUITING Phase N/A
NCT05044871 Biomarker-driven Targeted Therapy in Patients With Recurrent Platinum-resistant Epithelial Ovarian Cancer Status COMPLETED Phase PHASE2
NCT05044091 Homologous Recombination Deficiency in Chinese Ovarian Cancer Patients Status UNKNOWN Phase N/A
NCT05043922 A Study to Evaluate the Efficacy and Safety of CYH33 in Patients With Recurrent/Persistent Ovary Clear Cell Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05043402 A Study of Navicixizumab in Patients With Platinum Resistant Ovarian Cancer Status UNKNOWN Phase PHASE3